2-propanol has been researched along with valganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Los, LI; van Boxtel, LA; van der Lelij, A; van der Meer, J | 1 |
| Hove, M; Kjersem, B; Krohn, J; Thrane, AS | 1 |
2 other study(ies) available for 2-propanol and valganciclovir
| Article | Year |
|---|---|
Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients.
Topics: Adult; Anterior Chamber; Antiviral Agents; Aqueous Humor; Atrophy; Child; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Ganciclovir; Glaucoma; Humans; Immunocompetence; Intraocular Pressure; Iris; Male; Middle Aged; Recurrence; Retrospective Studies; Uveitis, Anterior; Valganciclovir; Visual Acuity | 2007 |
Acute retinal necrosis and ocular neovascularization caused by cytomegalovirus following intravitreal dexamethasone implant (Ozurdex
Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Drug Implants; Drug Therapy, Combination; Eye Infections, Viral; Fluorescein Angiography; Ganciclovir; Glucocorticoids; Humans; Intravitreal Injections; Iris; Laser Coagulation; Male; Neovascularization, Pathologic; Panuveitis; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Valganciclovir | 2016 |